We were very pleased with our choice to engage innoVitro’s contractility service. The studies using human iPSC-derived cardiomyocytes were tailored to our needs to provide results comparable to already existing (in house) data and the fast execution followed by a comprehensive study report completed the service perfectly.
News
- Cardiac Safety Symposium May 19 – 20, 2021Our partner Nanion Technologies will present this upcoming Cardiac Safety Symposium with keynote […]
- innoVation Series – Research Article of the Month – March 2021This month’s innovation series research article was published from our colleagues at the […]
- innoVation Series – Research Article of the Month – February 2021This month’s innovation series article deals with how to “sense” magnetic fields. […]
- Post date August 20, 2020